Moomoo AIのまとめ
SeaStar Medical Holding Corporation, a company listed on The Nasdaq Stock Market under the trading symbol ICU, held a virtual Special Meeting of stockholders on June 4, 2024. During the meeting, stockholders voted on several key proposals. Three Class II Directors were elected to serve until the 2027 annual meeting: Allan Collins, MD, Jennifer A. Baird, and Bernadette N. Vincent. An amendment and restatement of the Company's 2022 Omnibus Equity Incentive Plan was approved, increasing the authorized shares of common stock from 3,278,457 to 9,778,457. Additionally, the issuance of more than 20% of the Company's outstanding shares of Common Stock upon exercise of Series A and Series B Warrants was approved, in compliance with Nasdaq Listing Rule 5635(d). The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was also ratified.
SeaStar Medical Holding Corporation, a company listed on The Nasdaq Stock Market under the trading symbol ICU, held a virtual Special Meeting of stockholders on June 4, 2024. During the meeting, stockholders voted on several key proposals. Three Class II Directors were elected to serve until the 2027 annual meeting: Allan Collins, MD, Jennifer A. Baird, and Bernadette N. Vincent. An amendment and restatement of the Company's 2022 Omnibus Equity Incentive Plan was approved, increasing the authorized shares of common stock from 3,278,457 to 9,778,457. Additionally, the issuance of more than 20% of the Company's outstanding shares of Common Stock upon exercise of Series A and Series B Warrants was approved, in compliance with Nasdaq Listing Rule 5635(d). The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was also ratified.
ナスダック上場企業であるSeaStar Medical Holding Corporation（シンボル：ICU）は、2024年6月4日に仮想臨時株主総会を開催しました。総会では、株主がいくつかの重要提案について投票しました。3名の第IIクラスの取締役が選出され、2027年の定時株主総会まで務めます: Allan Collins、MD、Jennifer A. Baird、そしてBernadette N. Vincent。2022年のOmnibus Equity Incentive Planを改定して修正することが承認され、普通株式の承認済み株式数が3278457株から9778457株に増加しま...すべて展開
ナスダック上場企業であるSeaStar Medical Holding Corporation（シンボル：ICU）は、2024年6月4日に仮想臨時株主総会を開催しました。総会では、株主がいくつかの重要提案について投票しました。3名の第IIクラスの取締役が選出され、2027年の定時株主総会まで務めます: Allan Collins、MD、Jennifer A. Baird、そしてBernadette N. Vincent。2022年のOmnibus Equity Incentive Planを改定して修正することが承認され、普通株式の承認済み株式数が3278457株から9778457株に増加しました。さらに、Nasdaq Listing Rule 5635（d）に準拠して、Series AおよびSeries B Warrantsの行使により、発行済み普通株式の20％以上を発行することが承認されました。2024年12月31日までの会計年度において独立登録公認会計士事務所としてWithumSmith+Brown, PCの任命も承認されました。
役に立った
役に立たない